Whitehawk Therapeutics, Inc. (WHWK) — Financial Flexibility Index
Whitehawk Therapeutics, Inc. (WHWK) has a Financial Flexibility Index of -1.56x as of September 2025. Free cash flow of $-15.38 Million (operating CF $-15.38 Million minus capex $0.00) represents -2% of total liabilities ($9.85 Million). Check total reinvestment intensity of Whitehawk Therapeutics, Inc. to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Whitehawk Therapeutics, Inc. Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Whitehawk Therapeutics, Inc. across 6 annual periods. For the full cash flow conversion analysis, see Whitehawk Therapeutics, Inc. cash flow conversion.
Annual Financial Flexibility Index for Whitehawk Therapeutics, Inc. (2019–2024)
Year-by-year free cash flow to debt coverage for Whitehawk Therapeutics, Inc.. Explore Whitehawk Therapeutics, Inc. (WHWK) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -3.25x | $-57.90 Million | $-59.55 Million | $17.84 Million | ▼ -58.7% |
| 2023 | -2.05x | $-55.69 Million | $-59.66 Million | $27.23 Million | ▼ -7.5% |
| 2022 | -1.90x | $-49.20 Million | $-49.64 Million | $25.86 Million | ▼ -82.8% |
| 2021 | -1.04x | $-22.38 Million | $-22.42 Million | $21.50 Million | ▼ -156.1% |
| 2020 | -0.41x | $-12.70 Million | $-12.70 Million | $31.26 Million | ▼ -38.6% |
| 2019 | -0.29x | $-7.55 Million | $-7.58 Million | $25.75 Million | — |